FDA Will Review Johnson & Johnson Vaccine
Johnson & Johnson said its COVID vaccine candidate was 72% effective in a late stage trial.
A third vaccine is closer to getting approved in the U.S.
An independent advisory committee for the FDA will review the Johnson & Johnson vaccine candidate Friday.
In a late stage global trial, Johnson & Johnson said the shot was 72% effective in the U.S. and slightly less in countries where variants are more common, like South Africa.
If approved by the FDA, it would be the country's first single-dose vaccine. It can also be stored in a normal refrigerator.
President Biden to end emergency declarations for COVID
Those free at home COVID tests are expected to be a thing of the past after the emergency declaration ends.By Tsvangirayi Mukwazhi / AP
President Biden to end COVID-19 emergencies May 11
This comes as lawmakers have already ended elements of the emergencies that kept millions of Americans insured during the pandemic.By Susan Walsh / AP
WHO says COVID remains an emergency but is in transition
The World Health Organization said there is still uncertainty in COVID-19's future, but the virus is at a "transition point."By Shutterstock
Mount Washington to reach wind chills of -100F, as cold as Mars
The Mars Curiosity rover has recorded nighttime temperatures in recent days of 105 degrees below zero. Temperatures don't often get that low on Earth.By Robert F. Bukaty / AP
Why are more states changing pay transparency laws?
New laws mean more employers are required to share salary data with prospective employees.By Julia Nikhinson / AP
Man arrested in connection to Dallas Zoo monkey thefts
24-year-old Davion Irvin was booked into the Dallas County jail Thursday and charged with six counts of animal cruelty, police said.By Dallas Zoo